Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies

Angela Tincani, Flavio Allegri, Genesio Balestrieri, Guido Reber, Marielle Sanmarco, Pierluigi Meroni, Marie Claire Boffa

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Antiphospholipid ELISAs are part of the Antiphospholipid Antibodies Syndrome classification criteria, having the same diagnostic value as lupus anticoagulant. However, sometimes their results appear scarcely meaningful especially when wide metanalyses studies are performed, probably because of their well-known inter-laboratory variability. The application of a common protocol was shown to improve the test reproducibility, but this observation did not have any influence on the routine performances. After discussion among experts at the European level, we identified four conditions named "minimal requirements" considered useful to decrease the inter-laboratory variability:to run the samples in duplicate;to determine the cut off level in each laboratory analysing at least 50 samples from normal subjects, possibly age- and sex-matched with the patient population usually attending the Centre;to calculate the cut-off level in percentiles;to use stable external controls in the test. A collaborative study involving 36 European centres proved that the use of monoclonal anti-beta2 glycoprotein I antibodies, HCAL (IgG) and EY2C9 (IgM) as standards, can help to reduce the inter-laboratory coefficient of variation both in anticardiolipin (aCL) and anti-β2GPI (anti-beta2 glycoprotein I) ELISA. Therefore, we propose HCAL and EY2C9 as external controls, but other monoclonal or polyclonal preparations may be considered. During an interactive workshop held last May in Italy, 16 companies producing these tests agreed to consider the introduction of the "requirements" in their products. We suggest to adopt these "requirements" particularly in clinical studies, in order to compare more easily the literature data.

Original languageEnglish
Pages (from-to)553-558
Number of pages6
JournalThrombosis Research
Volume114
Issue number5-6 SPEC. ISS.
DOIs
Publication statusPublished - 2004

Fingerprint

Antiphospholipid Antibodies
beta 2-Glycoprotein I
Enzyme-Linked Immunosorbent Assay
Lupus Coagulation Inhibitor
Antiphospholipid Syndrome
Italy
Immunoglobulin M
Immunoglobulin G
Education
Antibodies
Population

Keywords

  • Anti-beta2 glycoprotein I
  • Anticardiolipin
  • Antiphospholipid antibodies immunoassays
  • Antiphospholipid Antibodies Syndrome
  • Cut-off
  • Standardization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. / Tincani, Angela; Allegri, Flavio; Balestrieri, Genesio; Reber, Guido; Sanmarco, Marielle; Meroni, Pierluigi; Boffa, Marie Claire.

In: Thrombosis Research, Vol. 114, No. 5-6 SPEC. ISS., 2004, p. 553-558.

Research output: Contribution to journalArticle

Tincani, Angela ; Allegri, Flavio ; Balestrieri, Genesio ; Reber, Guido ; Sanmarco, Marielle ; Meroni, Pierluigi ; Boffa, Marie Claire. / Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. In: Thrombosis Research. 2004 ; Vol. 114, No. 5-6 SPEC. ISS. pp. 553-558.
@article{b2e68150c36c426ea4468cdeb5447a88,
title = "Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies",
abstract = "Antiphospholipid ELISAs are part of the Antiphospholipid Antibodies Syndrome classification criteria, having the same diagnostic value as lupus anticoagulant. However, sometimes their results appear scarcely meaningful especially when wide metanalyses studies are performed, probably because of their well-known inter-laboratory variability. The application of a common protocol was shown to improve the test reproducibility, but this observation did not have any influence on the routine performances. After discussion among experts at the European level, we identified four conditions named {"}minimal requirements{"} considered useful to decrease the inter-laboratory variability:to run the samples in duplicate;to determine the cut off level in each laboratory analysing at least 50 samples from normal subjects, possibly age- and sex-matched with the patient population usually attending the Centre;to calculate the cut-off level in percentiles;to use stable external controls in the test. A collaborative study involving 36 European centres proved that the use of monoclonal anti-beta2 glycoprotein I antibodies, HCAL (IgG) and EY2C9 (IgM) as standards, can help to reduce the inter-laboratory coefficient of variation both in anticardiolipin (aCL) and anti-β2GPI (anti-beta2 glycoprotein I) ELISA. Therefore, we propose HCAL and EY2C9 as external controls, but other monoclonal or polyclonal preparations may be considered. During an interactive workshop held last May in Italy, 16 companies producing these tests agreed to consider the introduction of the {"}requirements{"} in their products. We suggest to adopt these {"}requirements{"} particularly in clinical studies, in order to compare more easily the literature data.",
keywords = "Anti-beta2 glycoprotein I, Anticardiolipin, Antiphospholipid antibodies immunoassays, Antiphospholipid Antibodies Syndrome, Cut-off, Standardization",
author = "Angela Tincani and Flavio Allegri and Genesio Balestrieri and Guido Reber and Marielle Sanmarco and Pierluigi Meroni and Boffa, {Marie Claire}",
year = "2004",
doi = "10.1016/j.thromres.2004.06.035",
language = "English",
volume = "114",
pages = "553--558",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "5-6 SPEC. ISS.",

}

TY - JOUR

T1 - Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies

AU - Tincani, Angela

AU - Allegri, Flavio

AU - Balestrieri, Genesio

AU - Reber, Guido

AU - Sanmarco, Marielle

AU - Meroni, Pierluigi

AU - Boffa, Marie Claire

PY - 2004

Y1 - 2004

N2 - Antiphospholipid ELISAs are part of the Antiphospholipid Antibodies Syndrome classification criteria, having the same diagnostic value as lupus anticoagulant. However, sometimes their results appear scarcely meaningful especially when wide metanalyses studies are performed, probably because of their well-known inter-laboratory variability. The application of a common protocol was shown to improve the test reproducibility, but this observation did not have any influence on the routine performances. After discussion among experts at the European level, we identified four conditions named "minimal requirements" considered useful to decrease the inter-laboratory variability:to run the samples in duplicate;to determine the cut off level in each laboratory analysing at least 50 samples from normal subjects, possibly age- and sex-matched with the patient population usually attending the Centre;to calculate the cut-off level in percentiles;to use stable external controls in the test. A collaborative study involving 36 European centres proved that the use of monoclonal anti-beta2 glycoprotein I antibodies, HCAL (IgG) and EY2C9 (IgM) as standards, can help to reduce the inter-laboratory coefficient of variation both in anticardiolipin (aCL) and anti-β2GPI (anti-beta2 glycoprotein I) ELISA. Therefore, we propose HCAL and EY2C9 as external controls, but other monoclonal or polyclonal preparations may be considered. During an interactive workshop held last May in Italy, 16 companies producing these tests agreed to consider the introduction of the "requirements" in their products. We suggest to adopt these "requirements" particularly in clinical studies, in order to compare more easily the literature data.

AB - Antiphospholipid ELISAs are part of the Antiphospholipid Antibodies Syndrome classification criteria, having the same diagnostic value as lupus anticoagulant. However, sometimes their results appear scarcely meaningful especially when wide metanalyses studies are performed, probably because of their well-known inter-laboratory variability. The application of a common protocol was shown to improve the test reproducibility, but this observation did not have any influence on the routine performances. After discussion among experts at the European level, we identified four conditions named "minimal requirements" considered useful to decrease the inter-laboratory variability:to run the samples in duplicate;to determine the cut off level in each laboratory analysing at least 50 samples from normal subjects, possibly age- and sex-matched with the patient population usually attending the Centre;to calculate the cut-off level in percentiles;to use stable external controls in the test. A collaborative study involving 36 European centres proved that the use of monoclonal anti-beta2 glycoprotein I antibodies, HCAL (IgG) and EY2C9 (IgM) as standards, can help to reduce the inter-laboratory coefficient of variation both in anticardiolipin (aCL) and anti-β2GPI (anti-beta2 glycoprotein I) ELISA. Therefore, we propose HCAL and EY2C9 as external controls, but other monoclonal or polyclonal preparations may be considered. During an interactive workshop held last May in Italy, 16 companies producing these tests agreed to consider the introduction of the "requirements" in their products. We suggest to adopt these "requirements" particularly in clinical studies, in order to compare more easily the literature data.

KW - Anti-beta2 glycoprotein I

KW - Anticardiolipin

KW - Antiphospholipid antibodies immunoassays

KW - Antiphospholipid Antibodies Syndrome

KW - Cut-off

KW - Standardization

UR - http://www.scopus.com/inward/record.url?scp=7044260448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044260448&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2004.06.035

DO - 10.1016/j.thromres.2004.06.035

M3 - Article

C2 - 15507291

AN - SCOPUS:7044260448

VL - 114

SP - 553

EP - 558

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 5-6 SPEC. ISS.

ER -